Award
NIH Reporter #5U01AR083132-03
Cannabidiol for postoperative Opioid Reduction in primary total Knee arthroplasty – a randomized, 2x2 factorial, double-blind, placebo-controlled clinical trial (The CORK trial)
Recipient
University of Michigan
Award Amount
$1,109,271.00
Ceiling
$1,109,271.00
Awarded
August 28, 2025
Identifier
5U01AR083132-03
NIH research grant for a clinical trial studying cannabidiol to reduce opioid use after knee surgery, funded by NIAMS with a budget of approximately $1.1 million for the initial year.
Description
A research grant opportunity for a clinical trial investigating the use of CBD to reduce opioid consumption after knee surgery. The project involves a multi-site, randomized controlled trial with detailed pharmacokinetic and safety assessments.